custom image

Joint meeting with: Obesity: From Cell to Patient

Diabetes: Many Faces of the Disease

February 1-3, 2021 | 10:00AM EST | 3:00PM UTC*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Diabetes continues to be a growing health problem throughout the world; the incidence of both type 1 diabetes (T1D) or type 2 diabetes (T2D) has steadily been rising. However, with the advent of novel technologies, high throughput sequencing, and clinical studies involving diverse human populations, there also has been a growing appreciation for the existence of sub-classifications of both T1D and T2D based on genetics and environmental influences. Understanding and characterizing the different diseases is critical to develop more effective personalized therapies. Therefore, the goal of this conference is to highlight traditional and novel aspects of diabetes research. This program will include lectures on atypical forms of T1D, as well as the emerging premise that beta cell dysfunction contributes to progression of this autoimmune disease. A dedicated session for T2D will highlight disease variations and challenge the current dogma associated with genetic and environmental differences between individuals. This conference is being held jointly with Obesity: From Cell to Patient. The program contains joint sessions, workshops, and even a joint Keynote speaker. The joint sessions will highlight the contribution of obesity to T2D pathogenesis, with an emphasis on novel areas of research, including the role of different types and sources of fat, exosome signaling and the role of the microbiome. Overall, this conference strives to raise awareness in the clinical and basic research communities about the need to sub-stratify diabetes to develop better treatment options.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 22, 2021
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk

#VKSDiabetes21



Program Details



Keynote Speaker


Morris White, PhD

Morris F. White, PhD
Boston Children's Hospital, Harvard Medical School



Speaking at this eSymposia


Emma Ahlqvist

Lund University, Sweden


Laura C. Alonso

Weill Cornell Medicine, USA


Ellen E. Blaak

Maastricht University, Netherlands


Joseph T. Brozinick

Eli Lilly and Company, USA


Michael A. Cowley

Monash University, Australia


Carmella Evans-Molina

Indiana University, USA


Jose C. Florez

Massachusetts General Hospital, USA


Paul W. Franks

Lund University, Sweden


Bret H. Goodpaster

Translational Research Institute for Metabolism and Diabetes, USA


Carla J. Greenbaum

Benaroya Research Institute at Virginia Mason, USA


Shane T. Hentges

Colorado State University, USA


Kevan C. Herold

Yale University, USA


Matthew B. Johnson

University of Exeter Medical School, UK


Alka M. Kanaya

University of California, San Francisco, USA


Allan Ertmann Karlsen

Novo Nordisk, Denmark


Chantal Mathieu

KU Leuven, Belgium


Rory J. McCrimmon

University of Dundee, UK


Martin G. Myers Jr.

University of Michigan, USA


Kristen Jane Nadeau

University of Colorado Denver, USA


Max Nieuwdorp

University of Amsterdam, Netherlands


Mary-Elizabeth Patti

Joslin Diabetes Center, USA


Marc Prentki

Montreal Diabetes Research Center, Canada


Michael W. Schwartz

University of Washington, USA


Lori Sussel

University of Colorado Anschutz Medical Campus, USA


Roy Taylor

Newcastle University, UK


Morris F. White

Boston Children's Hospital, Harvard Medical School, USA


Juleen R. Zierath

Karolinska Institutet, Sweden






Sponsors


sponsor-carousel-astraz.png

sponsor-carousel-novo-norodisk.png




Additional Support



sponsor-carousel-alpco.png

sponsor-carousel-bmgf.png

sponsor-carousel-nih-NIDDKD.png

sponsor-carousel-sable-systems.png

Funding for this conference was made possible (in part) by Grant No. 1 R13 DK127701-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

 

sponsor-carousel-scientist.png

 


#ScienceMustGoOn


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.





Donate to Keystone Symposia


custom image



Tags: eSymposia